Low-grade Albuminuria and the Incidence of Heart Failure in a Community-based Cohort of Elderly Men
Overview
Affiliations
Aims: To investigate associations of urinary albumin excretion rate (UAER) and heart failure (HF) incidence in a community-based sample.
Methods And Results: In a prospective study of 70-year-old men free from HF at baseline (n = 1106), UAER (from timed overnight samples) was analysed with established risk factors for HF [acute MI before baseline, acute MI during follow-up (modelled as a time-dependent covariate), hypertension, diabetes, left ventricular hypertrophy, smoking, body mass index, and glomerular filtration rate] and more recently described risk factors [high-sensitive C-reactive protein and insulin sensitivity (clamp glucose disposal rate)] as predictors of HF incidence. Ninety-eight participants developed HF during a median follow-up of 9.0 years. In Cox proportional hazards models adjusted for established and novel risk factors for HF, a 1 SD increase in log UAER increased the risk of HF in individuals without anti-hypertensive treatment (hazard ratio 1.49; 95% CI 1.13-1.98; P = 0.005). Furthermore, UAER remained an independent predictor of HF, also in participants without diabetes at baseline or myocardial infarction at baseline or during follow-up. There were no significant associations between UAER and HF incidence in individuals with anti-hypertensive treatment.
Conclusion: Our observations support the notion that low-grade albuminuria is a marker for subclinical cardiovascular damage that predisposes to future HF in the community.
Wang D, Kou P, Liao Y, Wang K, Yan Y, Chen C BMC Public Health. 2023; 23(1):666.
PMID: 37041564 PMC: 10088136. DOI: 10.1186/s12889-023-15613-y.
Tao J, Sang D, Zhen L, Zhang X, Li Y, Wang G Cardiovasc Diabetol. 2023; 22(1):70.
PMID: 36966320 PMC: 10040119. DOI: 10.1186/s12933-023-01796-6.
Alatas O, Biteker M, Demir A, Yildirim B, Acar E, Gokcek K Arq Bras Cardiol. 2022; 118(4):703-709.
PMID: 35137781 PMC: 9007018. DOI: 10.36660/abc.20201144.
Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.
Koniari I, Artopoulou E, Velissaris D, Ainslie M, Mplani V, Karavasili G J Geriatr Cardiol. 2021; 18(11):908-951.
PMID: 34908928 PMC: 8648548. DOI: 10.11909/j.issn.1671-5411.2021.11.010.
Linkens A, Houben A, Kroon A, Schram M, Berendschot T, Webers C Am J Clin Nutr. 2021; 115(2):444-455.
PMID: 34581759 PMC: 8827096. DOI: 10.1093/ajcn/nqab302.